Evidence map›Paper›PMID 32086638›Full record

ArticleJournal of industrial microbiology & biotechnology2020

Engineering a defined culture medium to grow Piscirickettsia salmonis for its use in vaccine formulations.

Pablo Fuentealba, Yesenia Latorre, Ernesto González, Irene Martínez, Carmen Soto, Claudia Altamirano

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Why vaccines fail againstFrontiers in immunology · 2022
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Pablo FuentealbaLaboratorio de Cultivos Celulares, Escuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Avenida Brasil, 2085, Valparaiso, Chile.
Yesenia LatorreLaboratorio de Cultivos Celulares, Escuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Avenida Brasil, 2085, Valparaiso, Chile.
Ernesto GonzálezLaboratorio de Cultivos Celulares, Escuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Avenida Brasil, 2085, Valparaiso, Chile.
Irene MartínezLaboratorio de Cultivos Celulares, Escuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Avenida Brasil, 2085, Valparaiso, Chile.
Carmen SotoCREAS CONICYT Regional GORE Valparaíso R0GI1004, Av. Universidad, Curauma, Chile.
Claudia AltamiranoLaboratorio de Cultivos Celulares, Escuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Avenida Brasil, 2085, Valparaiso, Chile. claudia.altamirano@pucv.cl.ORCID http://orcid.org/0000-0002-6389-086X
Pontificia Universidad Católica de Valparaíso · CLUniversity of Valparaíso · CL

Funding

CHEMICAL RECEPTOR EXPRESSIONF06TW001185 · FIC · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI DIONNE, VINCENT E · 1986 to 1986
–
Fondo de Fomento al Desarrollo Científico y Tecnológico D10I1185
6 · The paper itself

Abstract

Piscirickettsia salmonis is a facultative Gram-negative intracellular bacterium that produces piscirickettsiosis, disease that causes a high negative impact in salmonid cultures. The so-far-unidentified nutritional requirements have hindered its axenic culture at laboratory and industrial scales for the formulation of vaccines. The present study describes the development of a defined culture medium for P. salmonis. The culture medium was formulated through rational design involving auxotrophy test and statistical designs of experiments, considering the genome-scale metabolic reconstruction of P. salmonis reported by our group. The whole optimization process allowed for a twofold increase in biomass and a reduction of about 50% of the amino acids added to the culture medium. The final culture medium contains twelve amino acids, where glutamic acid, threonine and arginine were the main carbon and energy sources, supporting 1.65 g/L of biomass using 6.5 g/L of amino acids in the formulation. These results will contribute significantly to the development of new operational strategies to culture this bacterium for the production of vaccines.

Indexed as

Culture MediaPiscirickettsiaVaccinesCulture MediaVaccinesAmino acidDefined mediumNutritional requirementPiscirickettsia salmonisVaccines

Identifiers

PMID32086638
OpenAlexW3006805689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.